Knowledge Center

Article / Jun 08, 2009

A Well-Integrated Sideline. Deal to supply an inhaler device to Daiichi Sankyo marks a big victory for Hovione

Authors:
Source:
C&EN, 8 June, 2009

Spirits were high as Portugal-based executives from Hovione arrived in Cork, Ireland, in late April for the inauguration of the company's newly acquired pharmaceutical chemical facility. The acquisition, from Pfizer, closed on April 8, the same day as the company's 50th anniversary.

Related links

Read article here

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Speak Up!

An Ethics Line to enable team members to Speak Up!

Page
Read more

Sustainability

Hovione is committed to doing its part for a better world.

Page
Read more